Quality Management of Barrett's Esophagus

Area of Science:

• Gastroenterology
• Oncology
• Medical Quality Improvement

Background:

• Barrett's Esophagus (BE) is a significant risk factor for esophageal adenocarcinoma.
• Effective management of BE is crucial for improving patient outcomes and preventing cancer progression.

Purpose of the Study:

• To explore current evidence-based practices in the diagnosis, surveillance, and endoscopic treatment of BE.
• To emphasize quality indicators and emerging technologies in BE management.
• To promote standardization and training for enhanced early detection and prevention of neoplastic progression.

Main Methods:

• Review of current evidence-based practices in BE diagnosis, surveillance, and treatment.
• Focus on quality indicators: biopsy protocols, dysplasia detection, and surveillance intervals.
• Examination of emerging technologies like image-enhanced endoscopy and AI.

Main Results:

• Quality management in BE is essential for improving patient outcomes.
• Adherence to quality indicators like biopsy protocols and surveillance intervals is key.
• Emerging technologies and standardization can enhance early detection and prevention.

Conclusions:

• Aligning clinical practice with established quality benchmarks is vital for managing BE.
• Enhanced training, audit, and standardization are crucial for optimizing BE care.
• Improved quality management can significantly reduce the risk of neoplastic progression in BE patients.